HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Argon laser photocoagulation of the posterior segment in pseudophakia.

Abstract
A series of in vitro, in vivo, and clinical studies was performed to explore the safety and efficacy of argon laser and xenon arc photocoagulation in pseudophakia. The polymethylmethacrylate intracameral lens (Fyodorov) proved resistant to photothermal decomposition and allowed transmission of therapeutically effective energy levels to the retina. The argon laser delivered through a slit lamp and contact lens optical system appears to be the preferred method for posterior segment photocoagulation in pseudophakia. On the basis of five-day tissue culture studies and clinical experience of two years, the intracameral lens does not appear to be a toxic or transmission barrier to careful argon laser photocoagulation.
AuthorsT A Poole, M A Galin
JournalAmerican journal of ophthalmology (Am J Ophthalmol) Vol. 83 Issue 2 Pg. 185-7 (Feb 1977) ISSN: 0002-9394 [Print] United States
PMID556885 (Publication Type: Journal Article)
Chemical References
  • Methylmethacrylates
  • Xenon
  • Argon
Topics
  • Animals
  • Argon
  • Cats
  • Culture Techniques
  • Humans
  • Laser Therapy
  • Lasers (methods)
  • Lens, Crystalline (abnormalities, surgery)
  • Light Coagulation
  • Methylmethacrylates
  • Rabbits
  • Xenon

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: